Guidance on patient consultation. Current evidence for prostate-specific antigen screening in healthy men and treatment options for men with proven localised prostate cancer - Abstract

The main objective of this review is to summarise, for primary and secondary care doctors, the management options and current supporting evidence for clinically localised prostate cancer.

We review all aspects of management including current guidelines on early cancer detection and the importance of informed consent on PSA-based screening and assess the most common treatment options and the evidence for managing patients with low-, medium-, and high-risk disease.

Written by:
Pini G, Collins J, Ghadjar P, Wiklund P.   Are you the author?
Karolinska Institute, Department of Molecular Medicine and Surgery, Section of Urology, Solna, Stockholm, Sweden.  

Reference: Curr Urol Rep. 2015 May;16(5):502.
doi: 10.1007/s11934-015-0502-1

 
PubMed Abstract
PMID: 25773347

UroToday.com Prostate Cancer Section

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe